Table 5.
Major needs for reaching 2030 successfully with lymphatic filariasis MMDP activities
| Specific goal | Activities and issues | Advantage |
|---|---|---|
| Achieve the WHO dossier requirements | Increase national activities in MMDP in many countries | Is required for a country's eventual success in LF elimination validation |
| Reach 100% geographic coverage with MMDP | Increase national activities in MMDP | A dossier requirement |
| Improved data collection related to MMDP | Data recording | Improved reporting and availability of data for advocacy and dossier completion |
| Ensuring adequate medical care for chronic and serious LE patients | Better triage for the clinically difficult cases | Addresses UHC and sustainable development goals issues |
| Increase funding for MMDP | Advocacy and clear presentation of the successes | Addresses an important gap in programme needs |
| Empowerment of community healthcare providers through training and support | Increase the range of activities where HW can assist | Strengthens the health system |
| Continue focus on hydrocoelectomy campaigns | Reducing the final cases of hydrocoele | Achieves a successful dossier |
| Increased advocacy for the success of MMDP | Awareness by the community of the availability of medical care | Improved MMDP coverage |
| Continue to investigate ways to improve LE care | Research into new systemic and topical agents | Improved care |
| Increase availability of needed supplies | Supply ADL drugs, soaps and creams, ensure a clean water supply | Improve care for all affected LF patients |
| Accurate figures as to the numbers of LF patients receiving form GPELF | Improve reporting of MMDP activities by countries | Important to demonstrate the success of the programme through data related to patient care |